Whooping cough infection study in healthy adults
Part of Infections, Lungs & breathing clinical trials.
This study tests what happens when healthy adults are exposed to a special type of whooping cough bacteria. Results may help develop better vaccines to protect people from this infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old and in good general health.
- You have not had a pertussis (whooping cough) vaccine in the last 5 years or more than 7 total doses in your life.
- You do not have a long-term health condition like diabetes, asthma, heart disease, or a weakened immune system.
- You do not live or work closely with infants, pregnant women, elderly, or people with weak immune systems who are not up to date on their vaccines.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and helps the body build immunity.
This trial studies children who might have pertussis (“whooping cough”). It looks at children in outpatient/home-care settings when the child’s doctor suspects pertussis and orders a lab test, to help guide evaluation and care.
This study tests how well a “delayed antibiotic” plan works after being intentionally exposed to pertussis (whooping cough). It aims to learn whether delaying antibiotics for a short time is safe and useful, and you may be treated with an antibiotic if you become symptomatic.
This study looks at children with suspected pertussis (who need a PCR test) and compares how the bacteria and the immune response relate to how sick they become. It may help doctors understand why some children have worse symptoms and guide future care.
This trial tests a reduced-dose vaccine that protects against diphtheria, tetanus, and whooping cough (pertussis). It is designed for people 6 years and older who have not recently received other vaccines and are generally healthy.
This study checks on people who got a single dose of a whooping cough vaccine about 10 years ago in a previous study. Researchers want to see how well the vaccine is still working and if it is still safe.
Hear when a new Pertussis (Whooping Cough) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.